CABBI and Industry
One of the Center’s fundamental objectives is to translate its research results — whether in the form of new breeds of plants, new biofuels and other bio-based chemicals, lubricants, adhesives, etc., newly tested processes and applications, or new understandings about economic or ecological impacts — to commercial deployment. Deputy Director for Science & Technology Vijay Singh leads CABBI commercialization efforts.
Our research helps better inform both farmers and industry on adoption of the scientific advances made by CABBI experts. Further, the solutions our researchers find to current agricultural and bioeconomy issues are shared with farmers, ag lenders, and agribusiness, industry, and policy makers.
CABBI leadership is confident that partnering with the industrial community to scale up new bioproducts and new technologies is useful as both the corporate sector and our nation seek ways to lessen dependence on fossil fuels.
CABBI and the Integrated Bioprocessing Research Laboratory have introduced an Industrial Affiliates Program to further this initiative.
And the Center seeks input from the commercial side — as well as with academia and those in government — with its Strategic Advisory Board.
“We look forward to a day when we will have sustainable and economically sound production of fuels and chemicals from plants,” former CABBI Director Evan H. DeLucia said. “A vibrant bioeconomy based on plant products will enhance the economic and ecological resilience of U.S. agriculture.”
Royal DSM is a global, purpose-led, science-based company active in Nutrition, Health and Sustainable Living. DSM’s purpose is to create brighter lives for all. DSM addresses with its products and solutions some of the world’s biggest challenges while simultaneously creating economic, environmental and societal value for all its stakeholders — customers, employees, shareholders, and society at large.